Kortnye Smith

Rheumatic immune-related adverse events secondary to anti–programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series

Emma L. Mitchell, Peter K. H. Lau, Chloe Khoo et al. · European Journal of Cancer · 2018 · 93 citations

Life Sciences, Immunology, Oncology +17

Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion

Christopher R. McEvoy, Huiling Xu, Kortnye Smith et al. · Journal of Clinical Investigation · 2019 · 51 citations · Full text

Medicine, Oncology, Pharmacology +17

The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors

Julia Lai‐Kwon, Chloe Khoo, Serigne Lo et al. · Journal of Cancer Survivorship · 2019 · 45 citations

Medicine, Cancer Biology, Oncology +17

A Malignant Neoplasm From the Jejunum With a <i>MALAT1-GLI1</i> Fusion and 26-Year Survival History

Owen W.J. Prall, Christopher R. McEvoy, David J. Byrne et al. · International Journal of Surgical Pathology · 2020 · 39 citations

Veterinary Medicine, Oncology, Pathology +16

Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)

Peter K. H. Lau, Breon Feran, Lorey Smith et al. · Journal for ImmunoTherapy of Cancer · 2021 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +17